Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy
- 1 June 2005
- journal article
- clinical trial
- Published by Elsevier in Journal of Photochemistry and Photobiology B: Biology
- Vol. 79 (3) , 231-241
- https://doi.org/10.1016/j.jphotobiol.2004.09.013
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Optical Properties of Human Prostate at 732 nm Measured In Vivo during Motexafin Lutetium-Mediated Photodynamic TherapyPhotochemistry and Photobiology, 2004
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Texaphyrins: Synthesis and Development of a Novel Class of Therapeutic AgentsPublished by Wiley ,2001
- Localization and Efficacy Analysis of the Phototherapeutic Lutetium Texaphyrin (PCI‐0123) in the Murine EMT6 Sarcoma ModelPhotochemistry and Photobiology, 1997
- Changes in In Vivo Optical Properties and Light Distributions in Normal Canine Prostate during Photodynamic TherapyRadiation Research, 1997
- Transperineal Photodynamic Ablation of the Canine ProstateJournal of Urology, 1996
- Screening for early detection of prostate cancerThe Lancet, 1996
- Lutetium Texaphyrin (PCI‐0123): A Near‐Infrared, Water‐Soluble PhotosensitizerPhotochemistry and Photobiology, 1996
- Spatially resolved absolute diffuse reflectance measurements for noninvasive determination of the optical scattering and absorption coefficients of biological tissueApplied Optics, 1996
- OPTICAL PROPERTIES OF EXPERIMENTAL PROSTATE TUMORS in vivoPhotochemistry and Photobiology, 1993